FDA inspection
Hisun Pharmaceutical (Nantong) Co., Ltd.: FDA inspection ending Nov 15, 2019
FDA inspection 1111464 · Voluntary Action Indicated (VAI) · Nantong
Key facts
| Inspection ID | 1111464 |
|---|---|
| Firm | Hisun Pharmaceutical (Nantong) Co., Ltd. |
| FEI number | 3010956224 |
| Address | Rudong Coastal Economic, No 18 4th Haibin Road; Dev. Zone |
| City | Nantong |
| Country | China |
| Fiscal year | 2020 |
| Inspection end date | Nov 15, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data